These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 21709646)

  • 1. Modulating gut microbiota as an anti-diabetic mechanism of berberine.
    Han J; Lin H; Huang W
    Med Sci Monit; 2011 Jul; 17(7):RA164-7. PubMed ID: 21709646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota Are Attributable to Its Key Ingredient Berberine.
    Xu X; Gao Z; Yang F; Yang Y; Chen L; Han L; Zhao N; Xu J; Wang X; Ma Y; Shu L; Hu X; Lyu N; Pan Y; Zhu B; Zhao L; Tong X; Wang J
    Genomics Proteomics Bioinformatics; 2020 Dec; 18(6):721-736. PubMed ID: 33359679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice.
    Zhang W; Xu JH; Yu T; Chen QK
    Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
    Yao Y; Chen H; Yan L; Wang W; Wang D
    Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
    Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
    Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats.
    Zhang X; Zhao Y; Zhang M; Pang X; Xu J; Kang C; Li M; Zhang C; Zhang Z; Zhang Y; Li X; Ning G; Zhao L
    PLoS One; 2012; 7(8):e42529. PubMed ID: 22880019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus.
    Lv Y; Zhao X; Guo W; Gao Y; Yang S; Li Z; Wang G
    J Diabetes Res; 2018; 2018():1890978. PubMed ID: 29854817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats.
    Zhao JD; Li Y; Sun M; Yu CJ; Li JY; Wang SH; Yang D; Guo CL; Du X; Zhang WJ; Cheng RD; Diao XC; Fang ZH
    World J Gastroenterol; 2021 Feb; 27(8):708-724. PubMed ID: 33716449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).
    Zhang Y; Gu Y; Ren H; Wang S; Zhong H; Zhao X; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Kong P; Hou G; Gao M; Shi Z; Li X; Qiu Y; Zou Y; Yang H; Wang J; Xu G; Lai S; Li J; Ning G; Wang W
    Nat Commun; 2020 Oct; 11(1):5015. PubMed ID: 33024120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice.
    Xie W; Gu D; Li J; Cui K; Zhang Y
    PLoS One; 2011; 6(9):e24520. PubMed ID: 21915347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.
    Zhang X; Zhao Y; Xu J; Xue Z; Zhang M; Pang X; Zhang X; Zhao L
    Sci Rep; 2015 Sep; 5():14405. PubMed ID: 26396057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating the Gut Microbiota and Metabolites with Traditional Chinese Medicines: An Emerging Therapy for Type 2 Diabetes Mellitus and Its Complications.
    Jiang P; Di Z; Huang W; Xie L
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways.
    Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z
    Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Berberine regulates type 2 diabetes mellitus related with insulin resistance].
    Li C; He JZ; Zhou XD; Xu X
    Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2254-2260. PubMed ID: 28822177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRα and PPARα transcriptional programs.
    Liu X; Li G; Zhu H; Huang L; Liu Y; Ma C; Qin C
    Endocr J; 2010; 57(10):881-93. PubMed ID: 20724798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine acutely inhibits the digestion of maltose in the intestine.
    Li ZQ; Zuo DY; Qie XD; Qi H; Zhao MQ; Wu YL
    J Ethnopharmacol; 2012 Jul; 142(2):474-80. PubMed ID: 22626925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis.
    Zheng Y; Ding Q; Wei Y; Gou X; Tian J; Li M; Tong X
    Phytomedicine; 2021 Jul; 88():153455. PubMed ID: 33478831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of berberine alleviating metabolic disorder based on gut microbiome.
    Wang H; Zhang H; Gao Z; Zhang Q; Gu C
    Front Cell Infect Microbiol; 2022; 12():854885. PubMed ID: 36093200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.